Sort   by:  
 Page size 
UnknownRepression of LKB1 by miR-17∼92 Sensitizes MYC-Dependent Lymphoma to Biguanide Treatment.
Not available
S-EPMC7249503 | biostudies-literature
UnknownPhase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction.
Not available
S-EPMC8819907 | biostudies-literature
UnknownSafety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.
Not available
S-EPMC6524984 | biostudies-literature
UnknownReal-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Not available
S-EPMC6476457 | biostudies-literature
UnknownPhase 2 Study of Talazoparib in Patients With Homologous Recombination Repair-Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G.
Not available
S-EPMC8637652 | biostudies-literature
UnknownOlutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial.
Not available
S-EPMC11736922 | biostudies-literature
UnknownGenomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.
Not available
S-EPMC6425931 | biostudies-literature
UnknownOlutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML.
Not available
S-EPMC10362540 | biostudies-literature
UnknownSelinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.
Not available
S-EPMC9467680 | biostudies-literature
UnknownGenetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.
Not available
S-EPMC8725988 | biostudies-literature
Sort   by:  
 Page size